1 Vermeer SE, "Silent brain infarcts and the risk of dementia and cognitive decline" 348 : 1215-1222, 2003
2 Bruce DG, "Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study" 52 : 1808-1815, 2009
3 Deane R, "RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain" 9 : 907-913, 2003
4 Schneider JA, "Mixed brain pathologies account for most dementia cases in community-dwelling older persons" 69 : 2197-2204, 2007
5 Kimm H, "Mid-life and late-life vascular risk factors and dementia in Korean men and women" 52 : e117-e122, 2011
6 Launer LJ, "Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study" 70 : 774-780, 2011
7 Inzucchi SE, "Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes" 38 : 140-149, 2015
8 Lutgers HL, "Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10)" 4 : e6817-, 2009
9 Huskins WC, "Intervention to reduce transmission of resistant bacteria in intensive care" 364 : 1407-1418, 2011
10 ADVANCE Collaborative Group, "Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes" 358 : 2560-2572, 2008
1 Vermeer SE, "Silent brain infarcts and the risk of dementia and cognitive decline" 348 : 1215-1222, 2003
2 Bruce DG, "Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study" 52 : 1808-1815, 2009
3 Deane R, "RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain" 9 : 907-913, 2003
4 Schneider JA, "Mixed brain pathologies account for most dementia cases in community-dwelling older persons" 69 : 2197-2204, 2007
5 Kimm H, "Mid-life and late-life vascular risk factors and dementia in Korean men and women" 52 : e117-e122, 2011
6 Launer LJ, "Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study" 70 : 774-780, 2011
7 Inzucchi SE, "Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes" 38 : 140-149, 2015
8 Lutgers HL, "Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10)" 4 : e6817-, 2009
9 Huskins WC, "Intervention to reduce transmission of resistant bacteria in intensive care" 364 : 1407-1418, 2011
10 ADVANCE Collaborative Group, "Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes" 358 : 2560-2572, 2008
11 Lim S, "Improved glycemic control without hypoglycemia in elderly diabetic patients using the ubiquitous healthcare service, a new medical information system" 34 : 308-313, 2011
12 Whitmer RA, "Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus" 301 : 1565-1572, 2009
13 Chin SO, "Hypoglycemia is associated with dementia in elderly patients with type 2 diabetes mellitus: an analysis based on the Korea National Diabetes Program Cohort" 122 : 54-61, 2016
14 Abdelhafiz AH, "Hypoglycemia in older people: a less well recognized risk factor for frailty" 6 : 156-167, 2015
15 Rhee SY, "Hypoglycemia and medical expenses in patients with type 2 diabetes mellitus: an analysis based on the Korea National Diabetes Program Cohort" 11 : e0148630-, 2016
16 Sims-Robinson C, "How does diabetes accelerate Alzheimer disease pathology?" 6 : 551-559, 2010
17 De Felice FG, "How does brain insulin resistance develop in Alzheimer’s disease?" 10 (10): S26-S32, 2014
18 Duckworth W, "Glucose control and vascular complications in veterans with type 2 diabetes" 360 : 129-139, 2009
19 Mallery LH, "Evidence-informed guidelines for treating frail older adults with type 2 diabetes: from the Diabetes Care Program of Nova Scotia (DCPNS) and the Palliative and Therapeutic Harmonization (PATH) program" 14 : 801-808, 2013
20 Riddle MC, "Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial" 33 : 983-990, 2010
21 Action to Control Cardiovascular Risk in Diabetes Study Group, "Effects of intensive glucose lowering in type 2 diabetes" 358 : 2545-2559, 2008
22 Zilkens RR, "Earlier age of dementia onset and shorter survival times in dementia patients with diabetes" 177 : 1246-1254, 2013
23 Ott A, "Diabetes mellitus and the risk of dementia: the Rotterdam study" 53 : 1937-1942, 1999
24 Gudala K, "Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies" 4 : 640-650, 2013
25 Park CR, "Cognitive effects of insulin in the central nervous system" 25 : 311-323, 2001
26 Mathieu C, "Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics and DPP-4 inhibitors" (154) : 29-37, 2007